Pain Therapeutics' Shares Rally on Alzheimer's Study Grant

Pain Therapeutics, Inc. PTIE announced that the National Institutes of Health (NIH) has awarded a clinical research grant of $3.2 million to support a mid-stage study on its lead pipeline candidate, PTI-125, a small molecule being investigated for treating Alzheimer’s disease.